Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia

    ... in patients with refractory anemia with excess blasts , refractory anemia with excess blasts in transformation, or acute myeloid leukemia treated with this regimen ...

    Clinical Trial last updated 04/28/2016 - 8:49am.

  2. Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

    ... criteria21: Relapsed: Bone marrow blasts ≥5%; reappearance of blasts in the blood; development of extramedullary disease Refractory ...

    Clinical Trial last updated 06/06/2016 - 1:30pm.

  3. Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML)

    ... cells in the peripheral blood Less than 30% marrow blasts Absence of t(9:22) or BCR-ABL transcript Adequate major ...

    Clinical Trial last updated 07/14/2016 - 3:59pm.

  4. MDS—The Past 40 Years. A Look at the Emerging Awareness and Classification of Myelodysplastic Syndromes.

    ... CMML) and refractory anemia with excess blasts (RAEB) that could be confused with acute leukemia. These conditions ... until the end of the century. Based on the percentage of blasts (young, immature blood cells) in bone marrow and blood, the FAB ...

    Page last updated 10/19/2015 - 2:29pm.

  5. FAQs

    ... cells in your bone marrow being young white blood cells ( blasts ). About 30 out of 100 people with MDS will develop AML. Certain ... you have 3. Percentage of young white blood cells ( blasts ) in your bone marrow. 4. The number of cytogenetic changes you ...

    Topic section last updated 03/02/2016 - 11:42am.

  6. Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

    ... AML) as documented by the presence of >20% myeloid blasts in the bone marrow Subjects must be 18 years of age and ...

    Clinical Trial last updated 06/13/2016 - 3:24pm.

  7. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... Disease status: remission or <10% bone marrow blasts Myelodysplasia Acute lymphoblastic leukemia Disease status: ...

    Clinical Trial last updated 06/06/2016 - 3:10pm.

  8. Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

    ... MDS/CMML (defined as ≥ 10% peripheral blood or marrow blasts and/or IPSS score ≥ 1.5) and relapsed or refractory to ...

    Clinical Trial last updated 06/06/2016 - 10:47am.

  9. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... Disease status: remission or <10% bone marrow blasts Myelodysplasia Acute lymphoblastic leukemia Disease status: ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  10. Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia

    ... syndrome (MDS) (defined as having >/= 10% blasts in the bone marrow ) or patients with Chronic Myelomonocytic Leukemia (CMML) (having >/= 10% blasts in the bone marrow) may also be eligible after discussion with Principal ...

    Clinical Trial last updated 05/23/2016 - 3:37pm.